Omicron sub-variant BA.2’s offspring BA.2.38 has not led to any increase in hospitalisation or disease severity, and a few deaths reported recently are due to comorbidities, INSACOG said in its June 20 bulletin released on Sunday.

In the bulletin, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said many BA.2 cases have been reclassified to BA.2.38, which seems to be the prevalent sub-lineage in the latest sequencing batches, it said.